Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00937742 · ClinicalTrials.gov registry record · NA

The Effect of Processed Tomato Products on CVD Risks

A NA study of Cardiovascular Disease, sponsored by Penn State University.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT00937742 is a NA study of Cardiovascular Disease that has completed, run by Penn State University. The registered enrollment target is 32 participants, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00937742, a NA study of Cardiovascular Disease, has completed, sponsored by Penn State University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The primary working hypothesis is that consuming processed tomatoes frequently/daily will favorably improve endothelium and platelet function disease-risk biomarker profiles in adult men and women compared to consuming no or relatively low amounts of processed tomatoes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Tomato products

Study Locations (1)

Pennsylvania

  • Penn State University - University Park

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-01
Est. Completion 2009-04
Phase NA

Sponsor

Penn State University

219 total trials

What the Registry Record Tells You About NCT00937742

The ClinicalTrials.gov registry entry for NCT00937742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,713-participant average among 136 other Cardiovascular Disease trials with a reported enrollment target (99% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Tomato products is the first listed.

NCT00937742 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00937742 about?

NCT00937742 is a clinical study titled "The Effect of Processed Tomato Products on CVD Risks". The primary working hypothesis is that consuming processed tomatoes frequently/daily will favorably improve endothelium and platelet function disease-risk biomarker profiles in adult men and women compared to consuming no or relatively low amounts of processed tomatoes.

What is the current status of trial NCT00937742?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2008-01. Estimated completion is 2009-04.

What conditions does trial NCT00937742 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT00937742?

The interventions under investigation include: Tomato products (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00937742?

This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00937742 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.